Skip to main content
. 2020 Jan 16;19(3):2431–2445. doi: 10.3892/ol.2020.11311

Figure 5.

Figure 5.

Prognostic efficacy of FOXP4-AS1, BLACAT2 and UCC in GC evaluated using GEPIA. (A) Kaplan-Meier survival curves revealed that high FOXP4-AS1 expression significantly correlated with shorter DFS survival times of patients. (B) BLACAT2 expression levels were not significantly associated with GC prognosis. (C) UCC expression levels were not significantly associated with GC prognosis. GEPIA, Gene Expression Profiling Interactive Analysis; FOXP4-AS1, forkhead box P4 antisense RNA 1; BLACAT2, bladder cancer-associated transcript 2; UCC, upregulated in colorectal cancer.